98%
921
2 minutes
20
Purpose: Acute retinal necrosis (ARN) is a rare but severe ocular condition that often results in significant visual impairment or blindness. We aimed to determine whether ARN exhibits a distinct electroretinogram (ERG) waveform compared with other infectious and non-infectious uveitis forms.
Methods: This retrospective observational multicenter study included a total of 73 patients; 21 with ARN, 9 with bacterial endophthalmitis, 16 with other types of infectious uveitis, and 27 with non-infectious uveitis. Full-field electroretinography was performed at the initial examination to evaluate retinal function. Additionally, initial and post-treatment visual acuity were recorded. The a- and b-wave amplitudes were measured and compared between the groups.
Results: Patients with ARN had significantly reduced a- and b-wave amplitudes than the other types of infectious and non-infectious uveitis at the first visit ( < 0.01). Receiver operating characteristic analysis showed that an a-wave amplitude reduction of more than 73% discriminated ARN from other infectious uveitis with 75% sensitivity and 90% specificity (area under the curve [AUC] = 0.84), while a reduction greater than 49% discriminated ARN from non-infectious uveitis with 89% sensitivity and 76% specificity (AUC = 0.83). Pre-treatment visual acuity was the strongest predictor of visual prognosis.
Conclusions: ERG response is significantly reduced in the early stages of ARN. Therefore, ERG may serve as a valuable diagnostic tool for ARN, particularly when specialist examination or definitive diagnosis based on clinical findings is delayed. Given that early treatment improves the prognosis of ARN, this finding highlights the critical role of early diagnosis in preventing vision loss.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/09273948.2025.2532049 | DOI Listing |
Turk J Ophthalmol
August 2025
Eye Protection Foundation, Bayrampaşa Eye Hospital, İstanbul, Türkiye.
Objectives: To evaluate the indications, efficacy, and safety of adalimumab (ADA) in treating active non-infectious uveitis (NIU) in the Turkish population in a real-world setting.
Materials And Methods: This retrospective observational study included patients diagnosed with NIU treated with ADA on-label. The study assessed the impact of ADA treatment on best corrected visual acuity (BCVA), number of immunosuppressive therapies (IST), immunosuppressive drug load, and the frequency of required local treatment.
The conjunctiva is a central component of the ocular mucosal system and, together with the Meibomian glands of the eyelids and the lacrimal glands, fulfills nutritive and defensive functions on the ocular surface. The conjunctiva is integrated into a dense neural and immunological network called the "Conjunctiva-associated Lymphoid Tissue" (CALT) 1 2. This network perceives various stimuli and responds in a finely tuned manner to provide protection while minimizing collateral damage.
View Article and Find Full Text PDFBr J Ophthalmol
August 2025
Department of Ophthalmology, Fu Jen Catholic University College of Medicine, New Taipei, Taiwan
Background: Uveitis, an inflammation of the uveal tract, can lead to severe ocular complications and vision loss if left untreated. Cyclosporine has gained recognition as an effective immunosuppressive therapy, particularly as a steroid-sparing agent. This study aims to evaluate the efficacy and safety of cyclosporine in managing various types of uveitis, assess its safety profile and associated adverse effects, and compare its therapeutic effectiveness to other treatment options.
View Article and Find Full Text PDFFront Med (Lausanne)
July 2025
Unit of Ophthalmology, Department of Medicine, Surgery, and Neurosciences, University of Siena and Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory, and Autoimmune Diseases (RITA) Center], Siena, Italy.
Objectives: To detect factors capable of predicting the development of macular edema (ME) throughout the disease course in patients affected by non-infectious uveitis (NIU).
Methods: Predictive factors leading to the development of ME were analyzed through regression analysis. The functional impact of ME on best corrected visual acuity (BCVA) was also examined.
Ocul Immunol Inflamm
July 2025
Miyata Eye Hospital, Miyakonojo, Japan.
Purpose: To investigate the epidemiology, clinical features, laterality, and long-term visual prognosis of uveitis.
Methods: This is a retrospective observational study.
Results: We included 1362 patients diagnosed with uveitis at Miyata Eye Hospital, Japan, from 2015 to 2020.